Gloria Margison
Nurse Practitioner · Mc Kee, KYNPI 1134231285
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 660 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 37 manufacturers reported payments, led by AstraZeneca at 27.5% of the total. Among nurse practitioner clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 660 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Lilly USA, LLC$1K
- AbbVie$1K
- Bayer$864
- GSK$611
- Boehringer Ingelheim$564
- plus $5K from 31 others
What the payments were for
- Food & beverage$12,51999%
- Education$1041%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 106 | $3,467 |
| Lilly USA, LLC | 80 | $1,294 |
| AbbVie | 77 | $1,120 |
| Bayer | 41 | $864 |
| GSK | 38 | $611 |
| Boehringer Ingelheim | 38 | $564 |
| Novo Nordisk | 43 | $542 |
| Insulet Corporation | 23 | $435 |
| Merck | 26 | $417 |
| Corcept Therapeutics | 29 | $404 |
| Biohaven Pharmaceuticals, Inc. | 9 | $312 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 18 | $287 |
| Astellas Pharma US Inc | 16 | $281 |
| Sanofi-aventis U.S. LLC | 14 | $238 |
| Xeris Pharmaceuticals, Inc. | 11 | $204 |
| Pfizer | 10 | $185 |
| Novartis | 7 | $145 |
| Amgen | 7 | $143 |
| Verona Pharma, Inc. | 7 | $138 |
| Sunovion Pharmaceuticals Inc. | 10 | $136 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $112 |
| Ultragenyx Pharmaceutical Inc. | 5 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $84 |
| Phathom Pharmaceuticals, Inc. | 7 | $81 |
| Exact Sciences | 5 | $80 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $52 |
| Vanda Pharmaceuticals Inc. | 3 | $52 |
| Dexcom, Inc. | 2 | $50 |
| Eisai Inc. | 3 | $49 |
| Mylan Specialty L.p. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Abbott | 1 | $17 |
| Ascensia Diabetes Care US Inc. | 1 | $14 |
| Cequr Corporation | 1 | $13 |
| Genentech USA, Inc. | 2 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,623 in reported general payments places this provider in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 139 | $216,866 |
| MounjaroTirzepatide | 179 | $190,048 |
| FarxigaDapagliflozin Propanediol | 177 | $145,237 |
| EliquisApixaban | 117 | $95,462 |
| JardianceEmpagliflozin | 73 | $92,536 |
| KerendiaFinerenone | 42 | $48,160 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 43 | $47,987 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 19 | $41,021 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 43 | $39,615 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 53 | $35,612 |
| XareltoRivaroxaban | 36 | $34,932 |
| XifaxanRifaximin | 11 | $32,483 |
| TrulicityDulaglutide | 22 | $27,525 |
| EntrestoSacubitril/Valsartan | 18 | $21,697 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $15,969 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $1,294 | $220,974217 claims |
| Novo NordiskOzempic | $542 | $216,866139 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $3,467 | $180,849230 claims |
| PfizerEliquis | $185 | $95,462117 claims |
| Boehringer IngelheimJardiance | $564 | $92,53673 claims |
| BayerKerendia | $864 | $48,16042 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $238 | $39,61543 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $287 | $32,48311 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $611 | $29,41850 claims |
| NovartisEntresto | $145 | $21,69718 claims |
| AbbVieLinzess | $1,120 | $15,84522 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $18 | $11,25722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.
Other nurse practitioner in Mc Kee
- Rachael BradfordLexington$447K
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Ashley KnableLouisville$86K
- Christina BenningerLouisville$81K
- Courtney BowlingCampbellsville$47K
- Rebecca BraunerLouisville$40K
- Scott SeitzWinchester$34K
- Kristen KreinestEdgewood$34K
- Lillian ArgentEdgewood$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.